123 related articles for article (PubMed ID: 34230998)
1. Lifetime risks of hip fracture in patients with type 2 diabetic: Taiwan Diabetes Study.
Lin CC; Li CI; Liu CS; Wang MC; Lin CH; Lin WY; Yang SY; Li TC
Osteoporos Int; 2021 Dec; 32(12):2571-2582. PubMed ID: 34230998
[TBL] [Abstract][Full Text] [Related]
2. Use of thiazolidinediones and risk of hip fracture in old people in a case-control study in Taiwan.
Lin HF; Liao KF; Chang CM; Lin CL; Lin CH; Lai SW
Medicine (Baltimore); 2017 Sep; 96(36):e7712. PubMed ID: 28885328
[TBL] [Abstract][Full Text] [Related]
3. Severe hypoglycemia and hip fracture in patients with type 2 diabetes: a nationwide population-based cohort study.
Hung YC; Lin CC; Chen HJ; Chang MP; Huang KC; Chen YH; Chen CC
Osteoporos Int; 2017 Jul; 28(7):2053-2060. PubMed ID: 28374044
[TBL] [Abstract][Full Text] [Related]
4. Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs.
Colhoun HM; Livingstone SJ; Looker HC; Morris AD; Wild SH; Lindsay RS; Reed C; Donnan PT; Guthrie B; Leese GP; McKnight J; Pearson DW; Pearson E; Petrie JR; Philip S; Sattar N; Sullivan FM; McKeigue P;
Diabetologia; 2012 Nov; 55(11):2929-37. PubMed ID: 22945303
[TBL] [Abstract][Full Text] [Related]
5. Glycated Hemoglobin Level and Risk of Hip Fracture in Older People with Type 2 Diabetes: A Competing Risk Analysis of Taiwan Diabetes Cohort Study.
Li CI; Liu CS; Lin WY; Meng NH; Chen CC; Yang SY; Chen HJ; Lin CC; Li TC
J Bone Miner Res; 2015 Jul; 30(7):1338-46. PubMed ID: 25598134
[TBL] [Abstract][Full Text] [Related]
6. Visit-to-visit variation of fasting plasma glucose is a predictor of hip fracture in older persons with type 2 diabetes: the Taiwan Diabetes Study.
Chiang JI; Li TC; Li CI; Liu CS; Meng NH; Lin WY; Yang SY; Chen HJ; Lin CC
Osteoporos Int; 2016 Dec; 27(12):3587-3597. PubMed ID: 27363401
[TBL] [Abstract][Full Text] [Related]
7. Increased risks of hip fracture in diabetic patients of Taiwan: a population-based study.
Chen HF; Ho CA; Li CY
Diabetes Care; 2008 Jan; 31(1):75-80. PubMed ID: 17947342
[TBL] [Abstract][Full Text] [Related]
8. Impact of type 2 diabetes on postoperative outcome after hip fracture: nationwide population-based study in Taiwan.
Lee TC; Lee YL; Chen JC; Chen CH; Ho PS
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32086279
[TBL] [Abstract][Full Text] [Related]
9. Sulfonylurea use and risk of hip fractures among elderly men and women with type 2 diabetes.
Rajpathak SN; Fu C; Brodovicz KG; Engel SS; Lapane K
Drugs Aging; 2015 Apr; 32(4):321-7. PubMed ID: 25825122
[TBL] [Abstract][Full Text] [Related]
10. Visit-to-visit blood pressure variability and hip fracture risk in older persons.
Li TC; Li CI; Liu CS; Lin WY; Lin CH; Yang SY; Chiang JH; Lin CC
Osteoporos Int; 2019 Apr; 30(4):763-770. PubMed ID: 30789999
[TBL] [Abstract][Full Text] [Related]
11. Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study.
Driessen JH; van den Bergh JP; van Onzenoort HA; Henry RM; Leufkens HG; de Vries F
Diabetes Obes Metab; 2017 Mar; 19(3):421-428. PubMed ID: 27943565
[TBL] [Abstract][Full Text] [Related]
12. Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study.
Wong CKH; Man KKC; Shi M; Chan EW; Ho CW; Tse ETY; Wong ICK; Lam CLK
PLoS Med; 2019 Dec; 16(12):e1002999. PubMed ID: 31877127
[TBL] [Abstract][Full Text] [Related]
13. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
[TBL] [Abstract][Full Text] [Related]
14. The effect of pay for performance on risk incidence of hip fracture in type 2 diabetic patients: a nationwide population-based cohort study.
Lee YH; Kung PT; Kuo WY; Kao SL; Tsai WC
Medicine (Baltimore); 2020 Mar; 99(12):e19592. PubMed ID: 32195973
[TBL] [Abstract][Full Text] [Related]
15. Evidence from data searches and life-table analyses for gender-related differences in absolute risk of hip fracture after Colles' or spine fracture: Colles' fracture as an early and sensitive marker of skeletal fragility in white men.
Haentjens P; Johnell O; Kanis JA; Bouillon R; Cooper C; Lamraski G; Vanderschueren D; Kaufman JM; Boonen S;
J Bone Miner Res; 2004 Dec; 19(12):1933-44. PubMed ID: 15537435
[TBL] [Abstract][Full Text] [Related]
16. Risk of fracture with thiazolidinediones: disease or drugs?
Bazelier MT; Vestergaard P; Gallagher AM; van Staa TP; Cooper C; Leufkens HG; de Vries F
Calcif Tissue Int; 2012 Jun; 90(6):450-7. PubMed ID: 22488176
[TBL] [Abstract][Full Text] [Related]
17. Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?
Bazelier MT; Gallagher AM; van Staa TP; Cooper C; Leufkens HG; Vestergaard P; de Vries F
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):507-14. PubMed ID: 22392882
[TBL] [Abstract][Full Text] [Related]
18. Effects of thiazolidinediones on cardiovascular events in patients with type 2 diabetes mellitus after drug-eluting stent implantation: a retrospective cohort study using the national health insurance database in Taiwan.
Yeh HT; Hsieh CF; Tsai YW; Huang WF
Clin Ther; 2012 Apr; 34(4):885-93. PubMed ID: 22440193
[TBL] [Abstract][Full Text] [Related]
19. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
Mamza J; Mehta R; Donnelly R; Idris I
Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
[TBL] [Abstract][Full Text] [Related]
20. Hip, vertebral, and wrist fracture risks and schizophrenia: a nationwide longitudinal study.
Chu YW; Chen WP; Yang AC; Tsai SJ; Hu LY; Lee SC; Lee YT; Shen CC
BMC Psychiatry; 2022 Feb; 22(1):77. PubMed ID: 35105317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
